BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Coagulation
,
Allergy to pollen
,
Intestine
,
DNA fingerprint
,
Vitamin E
,
rs2476601
,
PPARA
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
acid sphingomyelin phosphodiesterase activity
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Colon cecum
Kidney
Fallopian tube
Mammary gland
Cervix
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Sphingomyelin/cholesterol lipidosis
Intestinal infection due to Pseudomonas
Prematurity of fetus
Myocardial ischemia
Musculoskeletal fibromatosis
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
chloroxylenol
Antigens, Neoplasm
indole
royal jelly
cortistatin A
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
rheb-1
Rpb4
Gata4
PRSS2
TWIST2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Functional constraints on the integrity of an ultra conserved region in Drosophila
Third instar larvae homozygous or heterozygous for dRIM2 knockout
D. melanogaster dHIF and dERR mutant larvae treated with hypoxia
Gene expression changes in the DHR96 mutant Drosophila melanogaster
C. elegan treated with hemin in cultured media
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for acid sphingomyelin phosphodiesterase activity
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
PRI-VENT FSGS: Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Tra…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ